TAK - Merck Reports Positive HIV Data And Other News: The Good Bad And Ugly Of Biopharma October, 13 2020 01:26 AM Takeda Pharmaceutical Company Limited American Depositary Shares Merck reports positive mid-stage data for HIV combo therapy. Takeda collaborates with Arrowhead Pharma for liver disease program. Xenon Pharmaceuticals receives FDA feedback for XEN496 phase 3 clinical trial. For further details see: Merck Reports Positive HIV Data, And Other News: The Good, Bad And Ugly Of Biopharma